These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 22355676)

  • 41. Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms.
    Yoshida K; Nagasaka T; Umeda Y; Tanaka T; Kimura K; Taniguchi F; Fuji T; Shigeyasu K; Mori Y; Yanai H; Yagi T; Goel A; Fujiwara T
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1557-69. PubMed ID: 27095449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct.
    Tsai JH; Liau JY; Yuan CT; Cheng ML; Yuan RH; Jeng YM
    Histopathology; 2017 Apr; 70(5):756-765. PubMed ID: 27864998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.
    Parvanescu A; Cros J; Ronot M; Hentic O; Grybek V; Couvelard A; Levy P; Chanson P; Ruszniewski P; Sauvanet A; Gaujoux S
    JAMA Surg; 2014 Aug; 149(8):858-62. PubMed ID: 24898823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.
    Omori Y; Ono Y; Tanino M; Karasaki H; Yamaguchi H; Furukawa T; Enomoto K; Ueda J; Sumi A; Katayama J; Muraki M; Taniue K; Takahashi K; Ambo Y; Shinohara T; Nishihara H; Sasajima J; Maguchi H; Mizukami Y; Okumura T; Tanaka S
    Gastroenterology; 2019 Feb; 156(3):647-661.e2. PubMed ID: 30342036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
    Huang B; Trujillo MA; Fujikura K; Qiu M; Chen F; Felsenstein M; Zhou C; Skaro M; Gauthier C; Macgregor-Das A; Hutchings D; Hong SM; Hruban RH; Eshleman JR; Thompson ED; Klein AP; Goggins M; Wood LD; Roberts NJ
    J Pathol; 2020 Nov; 252(3):252-262. PubMed ID: 32696980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serine/Threonine Kinase 11 Plays a Canonical Role in Malignant Progression of KRAS -Mutant and GNAS -Wild-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Omori Y; Ono Y; Morikawa T; Motoi F; Higuchi R; Yamamoto M; Hayakawa Y; Karasaki H; Mizukami Y; Unno M; Furukawa T
    Ann Surg; 2023 Feb; 277(2):e384-e395. PubMed ID: 33914475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights.
    Mas L; Lupinacci RM; Cros J; Bachet JB; Coulet F; Svrcek M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relevance of gene mutations and methylation to the growth of pancreatic intraductal papillary mucinous neoplasms based on pyrosequencing.
    Asano G; Miyabe K; Kato H; Yoshida M; Sawada T; Okamoto Y; Sahashi H; Atsuta N; Kachi K; Kato A; Jinno N; Natsume M; Hori Y; Naitoh I; Hayashi K; Matsuo Y; Takahashi S; Suzuki H; Kataoka H
    Sci Rep; 2022 Jan; 12(1):419. PubMed ID: 35013462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.
    Kawabata H; Ono Y; Tamamura N; Oyama K; Ueda J; Sato H; Takahashi K; Taniue K; Okada T; Fujibayashi S; Hayashi A; Goto T; Enomoto K; Konishi H; Fujiya M; Miyakawa K; Tanino M; Nishikawa Y; Koga D; Watanabe T; Maeda C; Karasaki H; Liss AS; Mizukami Y; Okumura T
    J Gastroenterol; 2022 Mar; 57(3):208-220. PubMed ID: 35018527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreas.
    Frampton AE; Stebbing J; Gall TM; Silver B; Jiao LR; Krell J
    Expert Rev Mol Diagn; 2015 Mar; 15(3):325-8. PubMed ID: 25656048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IPMNs with co-occurring invasive cancers: neighbours but not always relatives.
    Felsenstein M; Noë M; Masica DL; Hosoda W; Chianchiano P; Fischer CG; Lionheart G; Brosens LAA; Pea A; Yu J; Gemenetzis G; Groot VP; Makary MA; He J; Weiss MJ; Cameron JL; Wolfgang CL; Hruban RH; Roberts NJ; Karchin R; Goggins MG; Wood LD
    Gut; 2018 Sep; 67(9):1652-1662. PubMed ID: 29500184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression.
    Omori Y; Ono Y; Kobayashi T; Motoi F; Karasaki H; Mizukami Y; Makino N; Ueno Y; Unno M; Furukawa T
    Virchows Arch; 2020 Jul; 477(1):21-31. PubMed ID: 32291497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular Evidence for Monoclonal Skip Progression in Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Date K; Ohtsuka T; Fujimoto T; Tamura K; Kimura H; Matsunaga T; Mochidome N; Miyazaki T; Mori Y; Oda Y; Nakamura M; Tanaka M
    Ann Surg; 2017 May; 265(5):969-977. PubMed ID: 28398963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.
    Lee JH; Kim Y; Choi JW; Kim YS
    Springerplus; 2016; 5(1):1172. PubMed ID: 27512631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreas.
    Mateos RN; Nakagawa H; Hirono S; Takano S; Fukasawa M; Yanagisawa A; Yasukawa S; Maejima K; Oku-Sasaki A; Nakano K; Dutta M; Tanaka H; Miyano S; Enomoto N; Yamaue H; Nakai K; Fujita M
    Cancer Med; 2019 Aug; 8(10):4565-4573. PubMed ID: 31225717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Berger AW; Schwerdel D; Costa IG; Hackert T; Strobel O; Lam S; Barth TF; Schröppel B; Meining A; Büchler MW; Zenke M; Hermann PC; Seufferlein T; Kleger A
    Gastroenterology; 2016 Aug; 151(2):267-70. PubMed ID: 27343369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance.
    Okada T; Mizukami Y; Ono Y; Sato H; Hayashi A; Kawabata H; Koizumi K; Masuda S; Teshima S; Takahashi K; Katanuma A; Omori Y; Iwano H; Yamada M; Yokochi T; Asahara S; Kawakubo K; Kuwatani M; Sakamoto N; Enomoto K; Goto T; Sasajima J; Fujiya M; Ueda J; Matsumoto S; Taniue K; Sugitani A; Karasaki H; Okumura T
    J Gastroenterol; 2020 Dec; 55(12):1183-1193. PubMed ID: 32939577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.
    Park MA; Zaw T; Yoder SJ; Gomez M; Genilo-Delgado M; Basinski T; Katende E; Dam A; Mok SRS; Monteiro A; Mohammadi A; Jeong DK; Jiang K; Centeno BA; Hodul P; Malafa M; Fleming J; Chen DT; Mo Q; Teer JK; Permuth JB
    G3 (Bethesda); 2023 Feb; 13(2):. PubMed ID: 36454217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.
    Schönleben F; Qiu W; Remotti HE; Hohenberger W; Su GH
    Langenbecks Arch Surg; 2008 May; 393(3):289-96. PubMed ID: 18343945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.